期刊文献+

高肺血流对大鼠肺血管结构及尾加压素Ⅱ表达的影响 被引量:2

IMPACT OF HIGH PULMONARY BLOOD FLOW ON PULMONARY VASCULAR STRUCTURE AND HUMAN UROTENSIN Ⅱ IN INTRAPULMONARY ARTERIES OF RATS
下载PDF
导出
摘要 目的 :探讨新型血管活性肽人类尾加压素Ⅱ (hUⅡ )在高肺血流量所致肺动脉高压大鼠肺动脉中的表达及其作用。方法 :对大鼠行腹主动脉 下腔静脉分流术。 1 1周后 ,以右心导管法测肺动脉压力 ,观测肺血管显微结构的变化 ,以免疫组织化学方法检测肺动脉hUⅡ的表达。结果 :分流术后 1 1周 ,大鼠肺动脉高压形成 ,肺小血管肌化程度明显增强 ,肺中、小型肌型动脉相对中膜厚度明显增加。分流组大鼠肺动脉内皮细胞和平滑肌细胞hUⅡ蛋白表达上调 ,并且与肺动脉压力和肺血管结构的改变呈正相关。结论 :肺动脉内皮细胞和平滑肌细胞hUⅡ的上调可能参与了高肺血流量所致肺血管结构重建和肺动脉高压的形成。 Aim: To study human urotensin Ⅱ (hUⅡ) expression in intrapulmonary arteries of rats with pulmonary hypertension induced by high pulmonary blood flow and explore the role of hUⅡ in the development of pulmonary hypertension induced by left to right shunt. Methods: Aortocaval shunting was produced for 11 weeks in rats. Pulmonary artery mean pressure (PAMP) of each rat was evaluated using right cardiac catheterization. The pulmonary vascular structural changes,including the percentage of muscularized arteries of small pulmonary vessels and relative medial thickness of intra acinar pulmonary arteries were examined. Meanwhile, the expression of hUⅡ by pulmonary arteries was detected by immunohistochemistry. Results: After 11 week aortocaval shunting, PAMP was significantly increased. The percentage of muscularized arteries of small pulmonary vessels and relative medial thickness of pulmonary arteries were obviously increased in shunting rats compared with controls ( P <0.01, respectively). Meanwhile, hUⅡ expression by pulmonary artery endothelial cells and smooth muscle cells was significantly augmented in rats of shunt group, which was positively correlated with PAMP and the structural changes in pulmonary arteries. Conclusion: The up regulation of hUⅡ in pulmonary arteries might be involved in the development of pulmonary vascular structural remodeling and pulmonary hypertension induced by high pulmonary blood flow.
出处 《中国应用生理学杂志》 CAS CSCD 北大核心 2003年第3期274-277,T002,共5页 Chinese Journal of Applied Physiology
基金 北京大学生物医学跨学科研究项目 国家重点基础研究发展规划资助项目 (G2 0 0 0 0 56 90 5)
关键词 高肺血流 大鼠 肺血管结构 尾加压素Ⅱ 高血压 肺性 肺动脉 urotensin Ⅱ hypertension pulmonary left to right shunt pulmonary artery
  • 相关文献

参考文献9

  • 1齐永芬,卜定方,石彦荣,张勇刚,庞永正,唐朝枢,杜军保,牛大地,张勇刚,张正浩,唐朝枢.尾加压素Ⅱ促进大鼠血管平滑肌细胞内皮素生成[J].科学通报,2002,47(4):289-292. 被引量:10
  • 2齐建光,杜军保,李简,魏冰,唐朝枢.L-精氨酸对高肺血流量所致肺动脉高压的防治作用[J].实用儿科临床杂志,2001,16(5):263-265. 被引量:17
  • 3华毅.肺血管病的右心导管检查[A].程显声 主编.肺血管疾病学[C].北京:北京医科大学、中国协和医科大学联合出版社,1993.146-155.
  • 4田宏,杜军保,张宝红,赵卫红,唐朝枢.尾加压素对常氧及低氧大鼠肺动脉平滑肌细胞周期的影响[J].中国应用生理学杂志,2003,19(1):1-3. 被引量:3
  • 5Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning of cDNA encoding the urotensin Ⅱ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord [ J ]. Proc Natl Acad Sci USA, 1998,95 : 15803-15808.
  • 6Ames R S, Sarau H M, Chambers J K, et al. Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [ J ]. Nature, 1999, 401 :282-286.
  • 7MacLean M R, Alexander D, Stirrat A. Constractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat[J]. Br J Pharmacol, 2000, 130:201-204.
  • 8Douglas S A, Sulpizio A C, Piercy V, et al. Differential vasoconstrictor activity of human urotensin- Ⅱ in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey [ J ]. Br J Pharmacol, 2000,131 : 1262-1274.
  • 9Stirrat A, Gallagher M, Douglas S A. et al. Potent vasodilator responses to human urotensin- Ⅱ in human pulmonary and abdominal resistance arteries[J]. Am J Physiol, 2001, 280: H925-H928.

二级参考文献21

  • 1熊利泽,刘建平,曾祥龙,白晓光,巩固,熊东方,方福珍.吸入小剂量一氧化氮降低先天性心脏病肺动脉高压的初步研究[J].中国危重病急救医学,1997,9(4):206-207. 被引量:6
  • 2张勇刚 杨军 等.尾加压素II在心血管系统中的作用[J].北京医科大学学报,2000,32(2):133-133.
  • 3Coulouarn Y, Jegou S, Tostivint H, et al. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin Ⅱprecursors. FEBS-Lett, 1999, 457(1): 28~32
  • 4Ames R S, Sarau H M, Chambers J K, et al. Human urotensin Ⅱ: a potent vasoconstrictor and agonist for the orphan receptor GPR14.Nature, 1999, 401: 282~286
  • 5Liu Q, Pong S S, Zeng Z, et al. Identification of urotensin Ⅱ as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun, 1999, 266( 1 ): 174~178
  • 6Mori M, Sugo T, Abe M, et al. Urotensin Ⅱ is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).Biochem Biophys Res Commun, 1999, 265( 1 ): 123~129
  • 7Watanabe T, Pakala R, Katagiri T, et al. Synergistic effect of urotensin ii with mildly oxidized LdL on DNA synthesis in vascular smooth muscle cells. Circulation, 2001, 104( 1 ): 16~ 18
  • 8Sauzeau V, Le Mellionnec E. Human urotensin Ⅱ-induced contraction and arterial smooth muscle ceil proliferation are mediated by RhoA and Rho-kinase. Circ Res. 2001. 88(11):l102~1104
  • 9Oldroyd S D, Morcos S K. Endothelin: what does the radiologist need to know?. Br-J-Radiol, 2000, 73(876): 1246-1251
  • 10Campbell J H, Campbell G R. Culture techniques and their applications to studies of vascular smooth muscle. Clin Sci, 1993,85:501~512

共引文献27

同被引文献16

  • 1Bottrill E F,Douglas S A,Hiley C R,et al.Human uro-tensin-II is an endothelium-dependent vasodilator in ratsmall arteries[J].Br J Pharmacol,2000,130(8):1865-1870.
  • 2Douglas A S,Ohlstein H E.Human urotensin-II,themost potent mammalian vasoconstrictor identified to date,as a therapeutic target for the management of cardiovascu-lar disease[J].Trends Cardiovasc Med,2000,10(6):229-237.
  • 3Ames R S,Sarau H M,Chambers J K,et al.Humanurotensin-II is a potent vasoconstrictor and agonist for theorphan receptor GPR14[J].Nature,1999,401(6750):282-286.
  • 4Djordjevic T,Go¨rlach A.Urotensin-II in the lung:a mat-ter for vascular remodelling and pulmonary hypertension?[J].Thromb Haemost,2007,98(5):952-962.
  • 5Simpson C M,Penny D J,Stocker C F,et al.UrotensinII is raised in children w ith congenital heart disease[J].Scientific Letter,2006,92(7):983-984.
  • 6Watanabe T,Pakala R,Katagiri T,et al.Synergisticeffect of urotensin II w ith mildly oxidized LDL on DNAsynthesis in vascular smooth muscle cells[J].Circula-tion,2001,104(1):16-18.
  • 7Watanabe T,Pakala R,Katagiri T,et al.Synergisticeffect of urotensin II w ith serotonin on vascular smoothmuscle cell proliferation[J].J Hypertens,2001,19(12):2191-2196.
  • 8Sauzeau V,Le Mellionnec E,Bertoglio J,et al.Humanurotensin II-induced contraction and arterial smooth mus-cle cell proliferation are mediated by RhoA and Rho-Ki-nase[J].Circ Res,2001,88(11):1102-1104.
  • 9Guidolin D,Albertin G,Ribatti D.Urotensin-II as anangiogenic factor[J].Peptides,2010,31(6):1219-1224.
  • 10Roos-hesselink JW,Meijboom F J,Spitaels SE,et al.Outcome of patients after surgical closure of ventricular septal defect at young age:longitudinal follow-up of 22-34 years [J].Eur Heart J,2004,25(12):1057-1062.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部